SG Americas Securities
SLS icon

SG Americas Securities’s SELLAS Life Sciences SLS Stock Holding History

SG Americas Securities’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
19,039
+3,873
+26% +$26.7K ﹤0.01% 2625
2026
Q1 		$64K Sell
15,166
-21,284
-58% -$95.2K ﹤0.01% 3006
2025
Q4 		$137K Buy
36,450
+17,084
+88% +$33.2K ﹤0.01% 3089
2025
Q3 		$31K Sell
19,366
-1,544
-7% -$2.75K ﹤0.01% 3248
2025
Q2 		$46K Buy
+20,910
New +$32.1K ﹤0.01% 2769
2017
Q2 		– Sell
-84
Closed -$77K – 3477
2017
Q1 		$77K Buy
84
+66
+367% +$109K ﹤0.01% 3051
2016
Q4 		$51K Buy
+18
New +$105K ﹤0.01% 2933

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SG Americas Securities's SLS Position: Q2 2026 in Review

SG Americas Securities increased its SELLAS Life Sciences (SLS) stake by 26% in Q2 2026, buying an estimated $26.7K and bringing the position to 19,039 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

SG Americas Securities first reported a position in SLS in Q4 2016 and has held it in 7 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • SG Americas Securities held 19,039 shares of SELLAS Life Sciences worth $281K as of Q2 2026.
  • SG Americas Securities bought 3,873 SELLAS Life Sciences shares in Q2 2026, an estimated $26.7K.
  • SELLAS Life Sciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2625 holding.
  • SG Americas Securities first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 7 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.